Search

everythinglearnresearchcommunity

for

Search:↓

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Male pattern baldness does not cause an increased risk of prostate cancer.

Setipiprant did not significantly improve hair growth in men with hair loss.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

PRP treatment can increase hair growth in male pattern baldness, but this effect is not linked to the levels of growth factors or the number of platelets.

Caffeine can stimulate hair growth and counteract testosterone's suppressive effects on hair follicles.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Minoxidil can reduce functions related to androgen receptors.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Men with early-onset hair loss have more heart disease risk factors.

Topical finasteride is an effective and safer treatment for male hair loss.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Finasteride is more effective for hair loss in people with body hair.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Low-level laser therapy is about 80% effective in treating hair loss, with best results in males, those who use it for over a year, and those with scalp conditions like dandruff and rash.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Trichoscopy is useful for diagnosing and monitoring male pattern hair loss.

Both 5% minoxidil foam and liquid effectively treat hair loss, with foam slightly preferred.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.